Laffer Tengler Investments Viatris Inc Transaction History

Laffer Tengler Investments

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $1,975 - $2,253	219 New	219 $2.19 Million
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $34 - $46	-4 Reduced 1.79%	219 $2.44 Million
Q3 2021 Nov 16, 2021	BUY	$13.25 - $15.13 $2,954 - $3,373	223 New	223 $3.02 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $8,715 - $10,852	-672 Closed	0 $0
Q4 2020 Jun 11, 2021	BUY	$14.3 - $18.74 $9,609 - $12,593	672 New	672 $12.2 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

Stay updated on Laffer Tengler Investments with notifications on news.